Sign in
4

Changes in Ownership

Contineum Therapeutics, Inc. Filed Acc 0001437749-25-038936

Chief Scientific Officer sold 4,170 shares at $12.23 ($51,009)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lorrain Daniel S. · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-12-23 Sale : show line 1 in the form 10b5-1 −4,170 $12.23 $51,009 164,392 D
Open-market sales · 4,170 sh · avg $12.23 · $51,009
Loading xslF345X05/rdgdoc.xml…